Credit Suisse’s Sinovac Biotech, Ltd SVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-656
| Closed | -$1K | – | 4246 |
|
|
2022
Q3 | $1K | Hold |
656
| – | – | ﹤0.01% | 3991 |
|
|
2022
Q2 | $1K | Buy |
+656
| New | +$1K | ﹤0.01% | 3856 |
|
|
2018
Q1 | – | Sell |
-20,700
| Closed | -$163K | – | 3667 |
|
|
2017
Q4 | $163K | Sell |
20,700
-4,039
| -16% | -$31.8K | ﹤0.01% | 3284 |
|
|
2017
Q3 | $174K | Hold |
24,739
| – | – | ﹤0.01% | 3484 |
|
|
2017
Q2 | $167K | Hold |
24,739
| – | – | ﹤0.01% | 3265 |
|
|
2017
Q1 | $142K | Sell |
24,739
-199
| -0.8% | -$1.14K | ﹤0.01% | 3294 |
|
|
2016
Q4 | $147K | Sell |
24,938
-64,490
| -72% | -$380K | ﹤0.01% | 3523 |
|
|
2016
Q3 | $527K | Buy |
89,428
+29,085
| +48% | +$171K | ﹤0.01% | 3066 |
|
|
2016
Q2 | $358K | Buy |
+60,343
| New | +$358K | ﹤0.01% | 3308 |
|
|
2015
Q3 | – | Sell |
-48,551
| Closed | -$255K | – | 4406 |
|
|
2015
Q2 | $255K | Buy |
48,551
+8,095
| +20% | +$42.5K | ﹤0.01% | 3809 |
|
|
2015
Q1 | $201K | Buy |
40,456
+20,530
| +103% | +$102K | ﹤0.01% | 3807 |
|
|
2014
Q4 | $104K | Buy |
19,926
+9,170
| +85% | +$47.9K | ﹤0.01% | 4046 |
|
|
2014
Q3 | $51K | Sell |
10,756
-4,162
| -28% | -$19.7K | ﹤0.01% | 3957 |
|
|
2014
Q2 | $85K | Sell |
14,918
-33,326
| -69% | -$190K | ﹤0.01% | 4132 |
|
|
2014
Q1 | $347K | Buy |
+48,244
| New | +$347K | ﹤0.01% | 3620 |
|
|
2013
Q4 | – | Sell |
-25,961
| Closed | -$156K | – | 4255 |
|
|
2013
Q3 | $156K | Buy |
+25,961
| New | +$156K | ﹤0.01% | 3601 |
|